Double-Stranded RNA’s in Relation to Interferon Induction and Adjuvant Activity
The conduct of research in the medical sciences finds ample justification and support when it is targeted at an applied objective—that of producing something useful. New phenomena are eagerly sought that can be developed toward such an end. Hoskins’ (1935) discovery of the interference phenomenon is one such example, and its exciting possibilities were increasingly realized as its broad-spectrum antiviral nature was revealed. The epic discovery by Isaacs and Lindenmann (1957) of the protein mediator of interference, that is interferon, raised immediate hope for direct application to man but this has been subdued to date by problems of production and economic considerations (Hilleman, 1965; Ho and Postic, 1967; Merigan, 1967; Hilleman, 1968). The logical development, therefore, was the search for suitable inducers whereby the body could be stimulated to produce and distribute its own interferon. Early attack on the problem provided an abundance of inducers (Finter, 1966; Merigan and Regelson, 1967; Regelson, 1967) but none was of practical value because of infectiousness, extreme toxicity, antigenicity, and the like.
KeywordsHost Resistance Yellow Fever Virus Influenza Virus Vaccine Interferon Induction Penicillium Funiculosum
Unable to display preview. Download preview PDF.
- Field, A. K., Lampson, G. P., Tytell, A. A., Nemes, M. M., and Hilleman, M. R. (1967 a). Inducers of interferon and host resistance. IV. Double-stranded replicative form RNA (MS 2-RF-RNA) from E. coli infected with MS 2 coliphage. Proc. Natl. Acad. Sci. 58: 2102.Google Scholar
- Finter, N. B. (Ed.) (1966). Interferons, W. B. Saunders Co., Philadelphia.Google Scholar
- Hill, D. A., Baron, S., Levy, H. B., Bellanti, J., Buckler, C. E., Cannellos, G., Carbone, P., Chanock, R. M., De Vita, V., Guggenheim, M. A., Homan, E., Kapikian, A.Z., Kirschstein, R. L., Mills, J., Perkins, J. C., Van Kirk, J. E., and Worthington, M.: Personal communication, February, 1970.Google Scholar
- Hilleman, M. R. (1966). Critical appraisal of emulsified oil adjuvants applied to viral vaccines. Progr. Med. Virol. 8: 131.Google Scholar
- Hilleman, M. R. (1967). Considerations for safety and application of emulsified oil adjuvants to viral vaccines. Symp. Series Immunobiol. Standard. 13–26 Karger, Basel/New York.Google Scholar
- Ho, M. and Postic, B. (1967). Prospects for applying interferon to man. In First International Conference on Vaccines Against Viral and Rickettsial Diseases of Man, 632–649. Washington. Pan American Health Organization Scientific Publication No. 147.Google Scholar
- Hoskins, M. (1935). A protective action of neurotropic against viscerotropic yellow fever virus in macacus rhesus. Amer. J. Trop. Med. 15: 675.Google Scholar
- Janis, B. and Habel, K. (1970). Polyriboinosinic and polyribocytidylic acid polymer (poly I:C) in rabies prophylaxis. Fed. Proc. 29: 636.Google Scholar
- Lampson, G. P., Field, A. K., Tytell, A. A., Nemes, M. M., and Hilleman, M. R. (1970). Relationship of molecular size of rIn:rCn (poly I:C) to induction of interferon and host resistance. In Press. Proc. Soc. Exp. Biol. Med.Google Scholar
- Niblack, J. F., Knirsch, A. K., and Vora, K. R. M.: Personal communication, March, 1970.Google Scholar
- Postic, B. and Fenje, P. (1970). Prophylaxis of rabies in rabbits by poly I:C. Bact. Proc. 155.Google Scholar
- Regelson, W. (1967). Prevention and treatment of Friend leukemia virus (FLV) infection by interferon-inducing synthetic polyanions. In The Reticuloendothelial System and Atherosclerosis. Ed. by N. R. DiLuzio and R. Paoletti, 315–332. Plenum Press, New York.Google Scholar